2011
DOI: 10.2478/10004-1254-62-2011-2107
|View full text |Cite
|
Sign up to set email alerts
|

Cholinesterases: Structure, Role, and Inhibition

Abstract: Kolinesteraze: struktura, uloga, inhibicijaAcetilkolinesteraza (AChE; E.C. 3.1.1.7) i butirilkolinesteraza (BChE; E.C. 3.1.1.8) enzimi su koji se zbog svoje uloge u organizmu intenzivno istražuju unutar područja biomedicine i toksikologije. Iako strukturno homologni, ovi enzimi razlikuju se prema katalitičkoj aktivnosti, odnosno specifičnosti prema supstratima koje mogu hidrolizirati te selektivnosti za vezanje mnogih liganada. U ovom radu dan je pregled dosadašnjih istraživanja kolinesteraza i njihovih intera… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 91 publications
(189 reference statements)
0
4
0
Order By: Relevance
“…One of their clinical manifestations is the depletion of acetylcholine (ACh), a neurotransmitter in cholinergic synapses, caused by its excessive metabolism to choline and acetic acid mediated by cholinesterases. In humans, there are two cholinesterases: acetylcholinesterase (AChE), whose physiological role is to hydrolyse ACh, and butyrylcholinesterase (BChE), whose physiological role is still unclear, except that it hydrolyses ACh and other esters and scavenges some toxins by reacting with them before they reach AChE ( 70 , 71 , 72 ). Treatment of patients with neurodegenerative diseases who have low ACh levels (Alzheimer’s disease) and disorders of the neuromuscular system (Parkinson’s disease, myasthenia gravis) is focused on alleviating symptoms.…”
Section: Carbamates As Drugsmentioning
confidence: 99%
“…One of their clinical manifestations is the depletion of acetylcholine (ACh), a neurotransmitter in cholinergic synapses, caused by its excessive metabolism to choline and acetic acid mediated by cholinesterases. In humans, there are two cholinesterases: acetylcholinesterase (AChE), whose physiological role is to hydrolyse ACh, and butyrylcholinesterase (BChE), whose physiological role is still unclear, except that it hydrolyses ACh and other esters and scavenges some toxins by reacting with them before they reach AChE ( 70 , 71 , 72 ). Treatment of patients with neurodegenerative diseases who have low ACh levels (Alzheimer’s disease) and disorders of the neuromuscular system (Parkinson’s disease, myasthenia gravis) is focused on alleviating symptoms.…”
Section: Carbamates As Drugsmentioning
confidence: 99%
“…Organophosphorus compounds all commonly contains carbon and phosphorus, although some are known for being an inhibitor of AChE and content of pesticides, many does not [10]. Specifically those ones capable of creating coordinating covalent bond between the sulfur and phosphor atoms [21]. Another use of organophosphate is being applied to materials used for furniture, textiles and building materials as organophosphate flame retardants (OPFR).…”
Section: Chemicals With Similar Propertiesmentioning
confidence: 99%
“…Cholinesterases have different affinity for NA isomers due to the asymmetry of the ChE active sites gorge. AChE and BChE exhibit enantioselectivity, that is, preference for one enantiomer binding over another ( 11 , 25 , 44 , 45 , 46 ). For example, the P(−) isomers of sarin and VX are the most potent AChE inhibitors, and the C(+/−) P(−) isomers of soman are up to 50 times more toxic than the C(+/−) P(+) isomers ( 25 ).…”
Section: Cholinesterasesmentioning
confidence: 99%